Liver extraskeletal osteosarcoma

Summary

Liver extraskeletal osteosarcoma (MONDO:0003866) is a disease. A subtype of liver sarcoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	liver extraskeletal osteosarcoma
Mondo ID	MONDO:0003866
DOID	DOID:6370
NCIT	C5833
UMLS	C1333974
MedGen	232597
GARD	0023705
Anatomy (UBERON)	UBERON:0002107
Is cancer (heuristic)	no

Also known as: hepatic extraskeletal osteosarcoma · hepatic osteogenic sarcoma · hepatic osteosarcoma · liver extraskeletal osteosarcoma · liver osteogenic sarcoma · liver osteosarcoma · liver osteosarcoma (disease) · osteogenic sarcoma of liver · osteogenic sarcoma of the liver · osteosarcoma of liver · osteosarcoma of the liver

Disease family

This is a subtype of liver sarcoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system cancer › liver cancer › liver sarcoma › liver extraskeletal osteosarcoma

Related subtypes (6): liver angiosarcoma, liver rhabdomyosarcoma, bile duct sarcoma, liver leiomyosarcoma, liver fibrosarcoma, undifferentiated (embryonal) sarcoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.